OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
How to apply ALCOA+ to a laboratory building management system.
Data sharing facilitates traceability and boosts quality of APIs.
January 14, 2022
The UK’s National Institute of Health and Care Excellence has recommended the use of Janssen’s Darzalex (daratumumab) in combination with Velcade (bortezomib), thalidomide and dexamethasone (DVTd) to treat adults with multiple myeloma.
January 12, 2022
The Centers for Medicare and Medicaid Services took action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm (aducanumab).
January 10, 2022
FDA granted Oncoloze’s OM-301 an orphan drug designation for the treatment of acute myeloid leukemia (AML).
January 07, 2022
FDA amended it’s Emergency Use Authorization to shorten Moderna’s vaccine booster dose interval from six to five months.
FDA has cleared an IND from Poseida Therapeutics, allowing continued development of the company’s allogeneic CAR-T cell therapy candidate for treating multiple solid tumors.
Pharming Group, has been granted a positive opinion by EMA for its Paediatric Investigation Plan for leniolisib.
January 05, 2022
FDA maintained a steady pace in 2021 in approving important new therapies for market, including new vaccines and treatments for COVID-19.
Particle analysis provides assurances of the quality and performance of the final dosage form in pharmaceutical development.
Sample preparation tends to be manually labor intensive, but automating this step helps streamline the glycosylation monitoring workflow.